Comstock Holding Companies Inc (NASDAQ:CHCI), a homebuilding and multi-faceted real estate development and services company in the Washington, D.C. metropolitan area, announced a series of changes within its senior management team, including the resignation of Gregory V. Benson as President and Chief Operating Officer as of May 5, 2014. He remains on the Company’s Board of Directors. His current term will expire at the Company’s 2015 annual meeting of stockholders. Comstock Holding Companies Inc (NASDAQ:CHCI) net profit margin is -3.70%and weekly performance is -8.63%On last trading day company shares ended up $1.27. Analysts mean target price for the company is $1.00. Comstock Holding Companies Inc (NASDAQ:CHCI) distance from 50-day simple moving average (SMA50) is -19.99%.
Acorn Energy, Inc. (NASDAQ:ACFN) announced that John A. Moore, President & CEO of Acorn Energy, will host an investor call on Tuesday, May 13, 2014 at 11am EDT to discuss its first quarter 2014 results and developments. The Company will release financial results for the first quarter the afternoon of Monday, May 12th, after the market closes. Acorn Energy Inc (NASDAQ:ACFN) shares fell -5.12% in last trading session and ended the day on $2.04. ACFN Gross Margin is 23.90%and its return on assets is -57.20%.Acorn Energy Inc (NASDAQ:ACFN) quarterly performance is -43.65%
Zalicus (NASDAQ:ZLCS)‘s stock had its “neutral” rating reaffirmed by Zacks in a research note issued to investors on Friday, American Banking News.com reports. They currently have a target price on the stock. Zacks‘s price objective would indicate a potential upside from the stock’s previous close. Zalicus Inc (NASDAQ:ZLCS) shares moved down -6.25% in last trading session and was closed at $0.900, while trading in range of $0.86 – $0.94. Zalicus Inc (NASDAQ:ZLCS) year to date (YTD) performance is -18.92%.
CombiMatrix Corp (NASDAQ:CBMX, a molecular diagnostics company specializing in DNA-based testing services for developmental disorders and cancer diagnostics, announced record total quarterly revenues of $1.82 million for the first quarter 2014, The Company’s core prenatal microarray test volumes in the first quarter of 2014 grew 60 percent to a record of 737 tests from 461 tests in the first quarter of 2013 .CombiMatrix Corp (NASDAQ:CBMX) ended the last trading day at $2.10. Company weekly volatility is calculated as 9.56% and price to cash ratio as 1.66. CombiMatrix Corp (NASDAQ:CBMX) showed a negative weekly performance of -26.06%.